leadf
logo-loader
RNS
viewPolypipe

Polypipe Grp PLC - Director/PDMR Shareholding

RNS Number : 7716Z
Polypipe Group PLC
22 September 2020
 

Polypipe Group plc (the "Company")

Notification of transactions by Person Discharging Managerial Responsibilities

The Company announces that on 16 September 2020, Paul James, Chief Financial Officer and a Person Discharging Managerial Responsibilities, exercised a nil-cost option over 30,755 ordinary shares of £0.001 each in the capital of the Company ('Shares') in accordance with the Deferred Share Award that was granted to him on 21 March 2018.

Full details of the Award were included in a regulatory announcement released on 21 March 2018 and in the Company's 2017 Annual Report and Accounts. The Company's Employee Benefit Trust has today transferred 16,300 Shares to Mr James which represents the net number of Shares due to him after the appropriate tax and national insurance liabilities were taken into account.

The notification below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul James

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares for no consideration pursuant to the exercise of nil-cost options comprised in the Deferred Share Award  ("DSA") granted on 21 March 2018

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

16,300 - Number of DSA Shares acquired after reduction for appropriate tax and national insurance liabilities.

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

22 September 2020

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Enquiries:

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKBBPQBKDFCB

Quick facts: Polypipe

Price: 491

Market: LSE
Market Cap: £1.12 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read